Abstract
To standardize and improve the diagnosis and treatment level of chronic hepatitis B, clinical physicians should actively grasp the timing for initiating antiviral treatment, reasonably evaluate the selection of antiviral drugs, and pay close attention to the whole-process management of chronic HBV infection in their daily practice in order to reduce the risk of occurrence of serious diseases such as HCC. The concept of patient diagnosis and treatment plans should follow the treatment principles of the new version of the guidelines and formulate individualized treatment plans based on the actual situation of the patients. The development of academic activities and research should also start with solving problems found in practice or clinical needs so as to bring better diagnosis and treatment benefits to patients.